16-18
Jun
2026
CPHI & PMEC China 2026
Shanghai New International Expo Center
E2C51
6-8
Oct
2026
CPHI Milan 2026
Fiera Milano, Italy
8L14

Changsha Morning Shine Co., Ltd.

About Changsha Morning Shine Co., Ltd.

Morning Shine specializes in the supply of upstream core raw materials and biotechnology products for peptide, XDC, and nucleic acid therapeutics. We also provide custom chemical synthesis and CMO services, supporting projects from early development through GMP manufacturing.
Our portfolio includes industry-leading monodispersed PEG and derivatives, with PEG24 homolog impurities controlled below 0.15%, enabling improved performance in ADC, peptide, and oligonucleotide drug development.
We are also a leading supplier of peptide side chains and short peptides fragments, with the largest production capacity in China, high quality standards, and GMP-compliant manufacturing.

Meet us at

  • CPHI & PMEC China 2026

    Shanghai New International Expo Center
    16 Jun 2026 - 18 Jun 2026
  • CPHI Milan 2026

    Fiera Milano, Italy
    6 Oct 2026 - 8 Oct 2026
  • Country/Region:
    China
  • Founded:
    2019
  • On CPHI since:
    2025
  • Employees:
    250 - 499
Company types
Manufacturer/Innovator
Contact info

Products from Changsha Morning Shine Co., Ltd. (3)

Changsha Morning Shine Co., Ltd. Resources (1)

  • Brochure Morning Shine Product Catalog


    Morning Shine Pharma specializes in the supply of upstream core raw materials and biotechnology products for peptide, XDC, and nucleic acid therapeutics. We also provide custom chemical synthesis and CMO services, supporting projects from early development through GMP manufacturing.
    Our portfolio includes industry-leading monodispersed PEGs and derivatives, with PEG24 homolog impurities controlled below 0.15%, enabling improved performance in ADC, peptide, and oligonucleotide drug development.
    We are also a leading supplier of peptide side chains and short peptides, with the largest production capacity for side chains and short peptides in China, high quality standards, and GMP-compliant manufacturing.
    In the field of nucleic acid therapeutics, we offer high-quality GalNAc and Unylinker, with GalNAc purity above 99% and single impurities below 0.10%.